Mesalamine Tablet, Delayed Release
Product Images NDC 60687-408

4 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 60687-408). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ahp40825

Ahp40825
Mesalamine 800 mg delayed-release oral tablet, scored on one side, orange-brown in color with imprint '435' on one side. Manufactured by American Health Packaging.*
FDA Label Image

Blister

Blister
Mesalamine 800 mg delayed-release oral tablet carton label from American Health Packaging. The label displays the drug name, strength, dosage form, lot number, expiration date, barcode, and manufacturer information. It is designed for prescription use.*
FDA Label Image

Carton

Carton
Label for Mesalamine delayed-release tablets, USP, 800 mg strength. The label shows a package containing 30 tablets (5 x 6) for oral use, with instructions and storage information. The labeler is American Health Packaging, and the NDC is 60687-408-25. It includes dosage guidance, cautions, and manufacturer details from Zydus Pharmaceuticals.*
FDA Label Image

Structure

Structure
Chemical structure of Mesalamine, showing its molecular formula C7H7NO3 and molecular weight of 153.1. The diagram depicts the arrangement of atoms including a carboxyl group (COOH), amine group (NH2), and hydroxyl group (OH) bonded to a benzene ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.